Neurodegeneration with Brain Iron Accumulation (NBIA) Sequencing

  • Test Code:
    2101
  • Department:
  • Test Synonyms:
    NBIA NGS ATP13A2 C19orf12 COASY CP DCAF17 FA2H FTL FUCA1 KIF1A KMT2B (MLL2) PANK2 PLA2G6 SCP2 SCL39A14 SQSTM1 TRIM32 VPS13A WDR45
View Test

Neurodegeneration with Brain Iron Accumulation (NBIA), Deletion/Duplication

  • Test Code:
    2102
  • Department:
  • Test Synonyms:
    NBIA NGS ATP13A2 C19orf12 COASY CP DCAF17 FA2H FTL FUCA1 KIF1A PANK2 PLA2G6 SLC39A14 SQSTM1 TRIM32 VPS13A WDR45
View Test

Neurodegeneration with Brain Iron Accumulation (NBIA), Sequencing and Deletion/Duplication

  • Test Code:
    2100
  • Department:
  • Test Synonyms:
    NBIA NGS ATP13A2 C19orf12 COASY CP DCAF17 FA2H FTL FUCA1 KIF1A KMT2B (MLL4) PANK2 PLA2G6 SCP2 SLC39A14 SQSTM1 TRIM32 VPS13A WDR45
View Test

Neuroferritinopathy, FTL, Sequencing

  • Test Code:
    1550
  • Department:
  • Test Synonyms:
    Neurodegeneration with Brain Iron Accumulation NBIA Ferritinopathy Ferritin Light Chain FTL1
View Test

Non-Compaction Arrhythmogenic Left Ventricular Cardiomyopathy Panel

  • Test Code:
    1159
  • Department:
  • Test Synonyms:
    LVNC Intertrabecular Recesses ACTC1 ACTN2 DTNA LDB3 LMNA MYBPC3 MYH7 MYL3 TAZ TNNT2 TPM1 VCL
View Test

Noonan and Other Related Disorders

  • Test Code:
    2135
  • Department:
  • Test Synonyms:
    Cardiofaciocutaneous syndrome Costello syndrome Neurofibromatosis type 1 Legius syndrome Multiple Lentigenes LEOPARD syndrome Loose anagen hair (NSLAH) BRAF CBL HRAS KRAS MAP2K1 MAP2K2 NRAS PTPN11 RAF1 RIT1 SHOC2 SOS1 SPRED1
View Test

NRAS Mutation Analysis

  • Test Code:
    5100
  • Department:
  • Test Synonyms:
    NRAS Gene Mutation (exons 1, 2)
View Test

NSCLC FISH Panel (ALK, RET, ROS1, MET)

  • Test Code:
    7600
  • Department:
  • Test Synonyms:
    Lung Cancer FISH Panel GeneTrails FISH NSCLC FISH ALK RET ROS1 MET
View Test

Nucleophosmin Mutation Testing in Acute Myeloid Leukemia

View Test

The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of precision cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down just the cells that enable cancer to grow. This breakthrough has made once-fatal forms of the disease manageable and transformed how cancer is treated. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It is headquarters for one of the National Cancer Institute's largest research collaboratives, SWOG, in addition to offering the latest treatments and technologies as well as hundreds of research studies and clinical trials.

Learn More